These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7272412)

  • 1. Analysing data from hormone-receptor assays.
    Cressie NA; Keightley DD
    Biometrics; 1981 Jun; 37(2):235-49. PubMed ID: 7272412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Properties and interpretation of the Woolf and Scatchard plots in analysing data from steroid receptor assays.
    Keightley DD; Fisher RJ; Cressie NA
    J Steroid Biochem; 1983 Oct; 19(4):1407-12. PubMed ID: 6645483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A simple, low-cost computer program for Scatchard plot analysis of binding data in steroid hormone receptor assays.
    Kind G; Pollow K; Grill HJ; Manz B; Heubner A
    Exp Clin Endocrinol; 1985 Jun; 85(3):263-8. PubMed ID: 3840093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The two-state dimer receptor model: a general model for receptor dimers.
    Franco R; Casadó V; Mallol J; Ferrada C; Ferré S; Fuxe K; Cortés A; Ciruela F; Lluis C; Canela EI
    Mol Pharmacol; 2006 Jun; 69(6):1905-12. PubMed ID: 16501032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Fortran program for the calculation of estrogen receptor contents in human breast cancer.
    Zayas A; Lage A
    Neoplasma; 1981; 28(1):123-6. PubMed ID: 7279056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative characterization of hormone receptors.
    Rodbard D; Munson PJ; Thakur AK
    Cancer; 1980 Dec; 46(12 Suppl):2907-18. PubMed ID: 7448735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical detection of hormone receptors in breast carcinomas (ER-ICA, PgR-ICA): prognostic usefulness and comparison with the biochemical radioactive-ligand-binding assay (DCC).
    Beck T; Weikel W; Brumm C; Wilkens C; Pollow K; Knapstein PG
    Gynecol Oncol; 1994 May; 53(2):220-7. PubMed ID: 8188083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three radioligands compared for determining cytoplasmic estrogen-receptor content of human breast carcinomas.
    Pieslor PC; Gibson RE; Eckelman WC; Oates KK; Cook B; Reba RC
    Clin Chem; 1982 Mar; 28(3):532-7. PubMed ID: 7067100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal growth factor receptors in breast cancer: comparison of radioligand and immunocytochemical assays.
    Rallet A; Faroux MJ; Theobald S; Caquot LM; Pourny C; Pluot M; Jardillier JC
    Anticancer Res; 1994; 14(3B):1417-21. PubMed ID: 8067716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen receptor status in breast cancer.
    Wright CJ
    Can J Surg; 1980 Jul; 23(4):316-7. PubMed ID: 7417890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of bombesin/gastrin-releasing peptide receptors in human breast cancer and their relationship to steroid receptor expression.
    Halmos G; Wittliff JL; Schally AV
    Cancer Res; 1995 Jan; 55(2):280-7. PubMed ID: 7812958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The analysis of data from breast cancer estrogen and progesterone receptor assays: Scatchard plots are inferior to direct fitting by computer.
    Cooke RR; McIntosh JE
    Clin Chim Acta; 1986 Feb; 154(3):171-9. PubMed ID: 3955843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays.
    Regan MM; Viale G; Mastropasqua MG; Maiorano E; Golouh R; Carbone A; Brown B; Suurküla M; Langman G; Mazzucchelli L; Braye S; Grigolato P; Gelber RD; Castiglione-Gertsch M; Price KN; Coates AS; Goldhirsch A; Gusterson B;
    J Natl Cancer Inst; 2006 Nov; 98(21):1571-81. PubMed ID: 17077359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Residual plots for log odds ratio regression models.
    Tsujitani M; Koch GG
    Biometrics; 1991 Sep; 47(3):1135-41. PubMed ID: 1742433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Value of detection of hormone receptors by biochemical and immunochemical methods in therapeutic decision for breast cancer].
    Goussard J
    Bull Cancer; 1996 Dec; 83(12):1031-6. PubMed ID: 9116370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regression analysis of spatial data.
    Beale CM; Lennon JJ; Yearsley JM; Brewer MJ; Elston DA
    Ecol Lett; 2010 Feb; 13(2):246-64. PubMed ID: 20102373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination.
    Yu H; Levesque MA; Clark GM; Diamandis EP
    Br J Cancer; 1999 Oct; 81(3):490-5. PubMed ID: 10507775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Steroid hormone receptors and breast cancer].
    Thorpe SM; Rose C; Briand P
    Ugeskr Laeger; 1981 Jan; 143(4):194-9. PubMed ID: 7256962
    [No Abstract]   [Full Text] [Related]  

  • 19. [Current questions about estrogen receptor determination and hormone dependence (does estrogen receptor positivity equal estrogen dependence?)].
    Kahán Z
    Orv Hetil; 1996 Oct; 137(42):2305-8. PubMed ID: 8992428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of threshold values for determining the size of the fraction of steroid hormone receptor-positive tumor cells in paraffin-embedded breast carcinomas.
    Leers MP; Hoop JG; van Beers M; van Rodijnen N; Pannebakker M; Nap M
    Cytometry B Clin Cytom; 2005 Mar; 64(1):43-52. PubMed ID: 15668953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.